Publication | Open Access
Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration
11
Citations
33
References
2020
Year
Oral cFXST increases the efficacy of short-term ranibizumab treatment for exudative AMD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1